These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31305924)

  • 21. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy in children: The use of growth hormone and IGF-I.
    Pfäffle R
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):339-52. PubMed ID: 26051295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).
    Pfäffle R; Land C; Schönau E; Holterhus PM; Ross JL; Piras de Oliveira C; Child CJ; Benabbad I; Jia N; Jung H; Blum WF
    Horm Res Paediatr; 2018; 90(3):169-180. PubMed ID: 30199857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noonan syndrome and Turner syndrome patients respond similarly to 4 years' growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program.
    Lee PA; Ross JL; Pedersen BT; Kotnik P; Germak JA; Christesen HT
    Int J Pediatr Endocrinol; 2015; 2015(1):17. PubMed ID: 26351466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of guidelines for use of growth hormone in pediatric and transition patients.
    Cook DM; Rose SR
    Pituitary; 2012 Sep; 15(3):301-10. PubMed ID: 22271255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Growth hormone therapy].
    Krysiak R; Okopień B; Gdula-Dymek A
    Pol Merkur Lekarski; 2007 Apr; 22(130):305-11. PubMed ID: 17684932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Needle-Free and Needle-Based Growth Hormone Therapy in Children: A Pooled Analysis of Three Long-Term Observational Studies.
    Rohrer TR; Ceplis-Kastner S; Jorch N; Müller HL; Pfäffle R; Reinehr T; Richter-Unruh A; Weißenbacher C; Holterhus PM; Ferring Arzneimittel GmbH DSC
    Horm Res Paediatr; 2018; 90(6):393-406. PubMed ID: 30836359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Short Stature: Use of Growth Hormone in GH-Deficient and non-GH-Deficient Conditions.
    Vyas V; Menon RK
    Indian J Pediatr; 2021 Dec; 88(12):1203-1208. PubMed ID: 34609657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multiple indications for growth hormone treatment of pediatric patients.
    Farber RS; Kerrigan JR
    Pediatr Ann; 2006 Dec; 35(12):926-32. PubMed ID: 17236440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study.
    Angulo M; Abuzzahab MJ; Pietropoli A; Ostrow V; Kelepouris N; Tauber M
    Int J Pediatr Endocrinol; 2020 Nov; 2020(1):20. PubMed ID: 33292530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature.
    Rodríguez Arnao MD; Sánchez AR; García-Rey C; Arroyo Díez FJ; Estrada RC; Cuartero BG; Merillas MA; López-Siguero JP;
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1201-8. PubMed ID: 25210749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone therapy in children and adults.
    Krysiak R; Gdula-Dymek A; Bednarska-Czerwińska A; Okopień B
    Pharmacol Rep; 2007; 59(5):500-16. PubMed ID: 18048950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age.
    Kappelgaard AM; Laursen T
    Growth Horm IGF Res; 2011 Dec; 21(6):305-13. PubMed ID: 22019012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indications for growth hormone therapy in children.
    Kirk J
    Arch Dis Child; 2012 Jan; 97(1):63-8. PubMed ID: 21540481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Effectiveness and Safety of Childhood Growth Hormone Treatment in Noonan Syndrome.
    Rohrer TR; Abuzzahab J; Backeljauw P; Birkegård AC; Blair J; Dahlgren J; Júlíusson PB; Ostrow V; Pietropoli A; Polak M; Romano A; Ross J; Sävendahl L; Miller BS
    Horm Res Paediatr; 2020; 93(6):380-395. PubMed ID: 33440388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Growth Hormone Initiation Leads to Favorable Long-Term Growth Outcomes in Children Born Small for Gestational Age.
    Juul A; Backeljauw P; Cappa M; Pietropoli A; Kelepouris N; Linglart A; Pfäffle R; Geffner M
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1043-1052. PubMed ID: 36469726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recommendations for the clinical use of recombinant human growth hormone in children].
    ; ; ; ;
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):426-32. PubMed ID: 24120059
    [No Abstract]   [Full Text] [Related]  

  • 40. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study.
    Child CJ; Quigley CA; Cutler GB; Moore WV; Wintergerst KA; Ross JL; Rosenfeld RG; Blum WF
    Horm Res Paediatr; 2019; 91(4):241-251. PubMed ID: 31185471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.